How to Sell a Physical Therapy Practice in 2026: A Practical Guide for Owners

Selling a physical therapy practice is not like selling a medical clinic or a fitness business — buyers care about payer mix, referral patterns, and whether the practice can run without you. The market in 2026 is active, with PE-backed platforms and regional groups paying real premiums for the right practices. But the difference between a 4x and a 6.5x EBITDA outcome usually comes down to preparation, not luck. This guide walks you through who's buying, what they pay, and exactly how to position your practice for the top of the range.

Who Is Buying Physical Therapy Practices Right Now

Four distinct buyer groups are actively writing checks for PT practices in 2026, and each values your business differently.

PE-backed PT platforms are the most aggressive buyers. Groups like Confluent Health, Upstream Rehabilitation, and PT Solutions are rolling up regional practices to build scale. They pay the highest multiples — often 6x to 7x EBITDA — but only for practices doing $750K+ in EBITDA with clean financials and commercial-heavy payer mix.

Regional multi-site PT groups are buying smaller practices ($300K–$1M EBITDA) to fill in geographic gaps. They typically pay 4x to 5.5x and are more flexible on payer mix than PE platforms.

Hospital-affiliated outpatient groups acquire practices to capture referral funnels and expand their outpatient footprint. They move slower but pay competitive multiples in markets where they're trying to lock down referral sources.

DPT-led acquisitions are individual therapists or small partnerships buying their first or second clinic. They pay 3.5x to 4.5x, often with seller financing, and are realistic options for smaller single-location practices.

The most active geographic markets right now are Texas, Florida, North Carolina, Ohio, and Ontario — driven by population growth, favorable reimbursement, and platform consolidation.

What Buyers Pay: EBITDA Multiples Explained

PT practice valuations in 2026 fall into three clear tiers based on quality, scale, and payer mix.

Premium tier — 6x to 7x EBITDA

• $750K+ in adjusted EBITDA
• 70%+ commercial insurance
• Multiple tenured DPTs (owner not the primary producer)
• Diversified referrals (no physician above 20%)
• Modern EMR with clean billing data
• Multi-location or clearly scalable single site

Mid-market tier — 4.5x to 5.5x EBITDA

• $300K–$750K in EBITDA
• 50–70% commercial payer mix
• Owner produces some patient visits but not the majority
• Referral base diversified across 5–10 sources
• Functional EMR and billing process

Lower tier — 3.5x to 4.5x EBITDA

• Under $300K EBITDA, or owner is the sole/primary therapist
• Heavy Medicare/Medicaid exposure (>50%)
• One or two referring physicians driving most volume
• Manual billing or outdated systems
• Single location with limited growth runway

A practice doing $400K EBITDA can sell for $1.4M or $2.6M depending entirely on which tier it falls into. For a deeper breakdown, see our physical therapy practice valuation guide.

What Pushes Your Multiple Up

Six operational factors consistently move PT practices from the mid-tier into premium pricing.

• Commercial payer mix above 70%. Commercial insurance pays $95–$140 per visit versus Medicare's $75–$95. Buyers model your revenue per visit and a commercial-heavy book directly translates to higher EBITDA and a higher multiple on that EBITDA.

• Diversified referral sources. If no single physician or surgical group sends more than 20% of your patients, buyers see durable cash flow. A practice with 15 active referral sources is worth meaningfully more than one with 3, even at identical revenue.

• Tenured DPT staff. Buyers want to see DPTs who've been with you 3+ years and have established patient relationships. This proves the practice retains talent and that patients aren't loyal only to the owner.

• Owner not in the treatment room. If you're producing under 25% of visits yourself, your practice is genuinely transferable. This single factor can add a full turn to your multiple.

• Strong new patient pipeline. 25+ new evaluations per week per clinic, with documented marketing channels and direct access programs, signals growth and reduces buyer risk.

• Modern EMR and clean billing. WebPT, Raintree, or Net Health with organized payer data, low days in AR (under 35), and a denial rate under 5% — all of this reduces due diligence friction and supports a premium valuation.

What Pulls Your Multiple Down

Be honest about these before going to market. Buyers will find them in due diligence anyway.

• Medicare/Medicaid above 50% of revenue. Lower reimbursement, ongoing rate pressure, and regulatory exposure all compress multiples. A practice with 65% Medicare often sells for 3.5x–4x even with strong EBITDA.

• Referral concentration. If one orthopedic group sends 40% of your patients, buyers will assume that physician could retire, sell, or redirect referrals post-close. Expect a 0.5x–1x multiple haircut, or a significant earnout tied to retaining that source.

• High no-show and cancellation rates. Anything above 12% signals operational issues and lost revenue. Buyers will normalize EBITDA assuming improvement is possible, but they won't pay you for that upside.

• Manual billing or outdated EMR. If you're still using paper notes, legacy software, or outsourcing billing without clean reports, expect buyers to discount for integration risk and data quality concerns.

• Single-location with no scale plan. Practices that have plateaued at one location with no clear growth path get valued as cash-flow businesses, not platforms.

The Owner Dependency Problem

This is the single biggest valuation killer in PT practice sales — and the most fixable.

If you're the owner and you're also the primary treating therapist generating 50%+ of visits, buyers see a practice that doesn't exist without you. PE platforms won't touch it. Regional groups will heavily discount it. DPT buyers will offer 3.5x with most of it as seller financing.

The fix takes 12–24 months but is straightforward: hire and retain 2–3 additional DPTs, transition your patient panel to them, and reduce your own clinical hours to under 25% of practice volume. Document this transition in your production reports so buyers can see the trend.

A practice where the owner produces 60% of visits might sell for 3.5x. The same practice 18 months later with the owner at 20% of visits can command 5.5x or more. On $400K of EBITDA, that's the difference between $1.4M and $2.2M+ — for the same business.

If you're planning to sell in 2026 or 2027, the staffing decisions you make right now matter more than any other lever.

What Buyers Look At in Due Diligence

Once you're under LOI, expect a 60–90 day diligence process. Buyers and their advisors will request:

• Three years of financials — P&Ls, balance sheets, tax returns, and a quality of earnings analysis on practices over $1M revenue
• Payer mix breakdown by month — gross and net collections by payer, with revenue per visit trends
• Referral source report — visits and revenue attributed to each referring physician or source over 24 months
• Provider productivity reports — visits per DPT, revenue per DPT, and patient retention by therapist
• AR aging and denial reports — days in AR, denial rate, write-offs, and payer-specific collection issues
• Patient volume metrics — new evaluations per month, total visits, no-show rate, cancellation rate, average visits per episode of care
• Staff details — DPT licenses, tenure, compensation, non-competes, and PTA/aide structure
• Lease and compliance — facility lease terms, Medicare enrollment status, state board compliance, and any past audits or investigations

Practices that can produce this package quickly close faster and at higher prices. Practices that scramble for 6 weeks to pull reports together get re-traded.

Common Mistakes Sellers Make

After seeing hundreds of PT practice transactions, these are the mistakes that cost owners real money.

• Going to market too early. Selling the year after you finally hired your second DPT means the buyer doesn't see proof that the model works without you. Wait 12–18 months and document the transition.

• Not normalizing EBITDA properly. Your above-market salary, personal vehicle, family on payroll, and one-time expenses should all be added back — but do it with documentation. Aggressive adjustments without backup get rejected and damage credibility.

• Talking to only one buyer. Owners who get an unsolicited offer and run with it leave 20–40% on the table. A competitive process with 4–6 qualified buyers consistently produces better price and terms.

• Ignoring the referral conversation. If your top referring physician finds out you're selling from someone else, that relationship can collapse before closing. Plan the communication carefully with your advisor.

• Underestimating the transition period. Most buyers want the seller to stay 12–24 months post-close, often with a meaningful equity rollover. If you wanted to be on a beach 60 days after closing, you should have started planning three years ago. For more on this, see how to sell a physical therapy practice.

Frequently Asked Questions

What is a good EBITDA multiple for a physical therapy practice?

In 2026, PT practices sell between 3.5x and 7x EBITDA. Premium practices with $750K+ EBITDA, 70%+ commercial payer mix, and a tenured DPT staff that doesn't depend on the owner can hit 6x–7x. Most mid-market single-location practices sell in the 4.5x–5.5x range.

How long does it take to sell a physical therapy practice?

From listing to close, plan on 6–9 months for a typical practice. The first 60–90 days is buyer outreach and offers, then 60–90 days under LOI for due diligence and legal, then 30 days to close. Practices with messy financials or referral concentration issues can take 12+ months.

Do I need to stay after selling my physical therapy practice?

Almost always yes. PE-backed buyers typically require 2–3 years of post-close involvement plus a 15–30% equity rollover. Regional groups want 12–24 months of transition. Only smaller DPT-led acquisitions offer clean 6–12 month exits, and usually at lower multiples.

How does payer mix affect my practice's value?

Significantly. Commercial insurance pays $95–$140 per visit versus Medicare at $75–$95. A practice with 70%+ commercial payer mix can command 6x+ EBITDA, while a Medicare-heavy practice (50%+) often sells at 3.5x–4x even with strong EBITDA. Payer mix affects both your EBITDA and the multiple buyers apply to it.

Should I use a broker or marketplace to sell my PT practice?

For practices under $300K EBITDA, a direct sale via a marketplace to a DPT buyer often works well. For practices above $500K EBITDA, you should run a competitive process with multiple qualified buyers — going to a single buyer typically costs you 20–40% of your sale price.

What documents do I need to sell a physical therapy practice?

At minimum: 3 years of financials and tax returns, payer mix reports, referral source reports by physician, provider productivity data, AR aging, patient volume metrics (new evals, visits, no-show rate), DPT staff details with tenure and contracts, facility lease, and Medicare enrollment documentation. Having these ready before going to market accelerates closing and supports a higher price.

Can I sell my practice if I'm the only therapist?

Yes, but expect a discounted multiple — usually 3.5x–4x — and the buyer pool will be limited to individual DPTs or small regional groups. PE-backed platforms generally won't acquire owner-dependent practices. If possible, hire 1–2 additional DPTs and transition patients for 12–18 months before selling to meaningfully increase your sale price.